Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

29 mars 2026 21h44 HE | Source: The Rosen Law Firm PA

ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages Enphase Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ENPH

NEW YORK, March 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Enphase Energy, Inc. (NASDAQ: ENPH) between April 22, 2025...
29 mars 2026 21h16 HE | Source: The Rosen Law Firm PA

ROSEN, NATIONAL TRIAL COUNSEL, Encourages Concorde International Group Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CIGL

NEW YORK, March 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Concorde...
29 mars 2026 21h11 HE | Source: The Rosen Law Firm PA

ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Corcept Therapeutics Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – CORT

NEW YORK, March 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between...
29 mars 2026 20h58 HE | Source: The Rosen Law Firm PA

TCPC IMPORTANT DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages BlackRock TCP Capital Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action – TCPC

NEW YORK, March 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BlackRock TCP Capital Corp. (NASDAQ: TCPC) between November...
29 mars 2026 20h34 HE | Source: Major League Fishing

Jacob Wheeler Earns 11th Bass Pro Tour Win at Suzuki Marine Stage 4 Presented by Plano

EARLY, Texas, March 29, 2026 (GLOBE NEWSWIRE) -- Throughout the first two days of Suzuki Marine Stage 4 Presented by Plano, Jacob Wheeler worried that every scorable bass he caught hampered his...
29 mars 2026 20h07 HE | Source: The Rosen Law Firm PA

RR DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Richtech Robotics Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 3 Deadline in Securities Class Action Commenced by the Firm – RR

NEW YORK, March 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Richtech Robotics Inc. (NASDAQ: RR) between January 27,...
29 mars 2026 20h06 HE | Source: The Rosen Law Firm PA

MASONITE DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Masonite International Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - DOOR

NEW YORK, March 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of Masonite International Corporation (NYSE: DOOR) between June...
29 mars 2026 19h28 HE | Source: The Rosen Law Firm PA

ROSEN, THE FIRST FILING FIRM, Encourages Franklin BSP Realty Trust, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – FBRT

NEW YORK, March 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Franklin BSP Realty Trust, Inc. (NYSE: FBRT) between...
29 mars 2026 18h16 HE | Source: Alkane Resources Limited

Alkane Executes $110 Million Revolving Credit Facility

Alkane Executes $110 Million Revolving Credit Facility
29 mars 2026 12h40 HE | Source: Robbins Geller Rudman & Dowd LLP

INVESTOR ALERT: Ultragenyx Pharmaceutical Inc. (RARE) Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - RGRD Law

Ultragenyx allegedly misled investors about setrusumab’s potential Phase 3 study success in reducing fracture rates.

Page précédente

Page suivante